Home›Epinephrine 0.3 Adults

Epinephrine 0.3 Adults

Also known as: Epinephrine 0.3 Adults

alpha-Adrenergic Agonistbeta-Adrenergic AgonistCatecholamine

Route: Subcutaneous

Check Epinephrine 0.3 Adults Interactions →

12 interactions on record

Epinephrine 0.3 Adults has 12 known drug interactions based on U.S. FDA drug labeling data. 12 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Anti-Arrhythmics, Cardiac Glycosides, Chlorpheniramine. Patients taking Epinephrine 0.3 Adults should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total: 12
Major: 12

Major (12)

Epinephrine 0.3 Adults + Anti-Arrhythmics— Patients receiving epinephrine with anti-arrhythmics should be observed carefully for development of cardiac arrhythmias…
Epinephrine 0.3 Adults + Cardiac Glycosides— Patients receiving epinephrine with cardiac glycosides should be observed carefully for development of cardiac arrhythmi…
Epinephrine 0.3 Adults + Chlorpheniramine— Effects of epinephrine may be potentiated by chlorpheniramine.
Epinephrine 0.3 Adults + Diphenhydramine— Effects of epinephrine may be potentiated by diphenhydramine.
Epinephrine 0.3 Adults + Diuretics— Patients receiving epinephrine with diuretics should be observed carefully for development of cardiac arrhythmias.
Epinephrine 0.3 Adults + Ergot Alkaloids— Ergot alkaloids may reverse the pressor effects of epinephrine.
Epinephrine 0.3 Adults + Levothyroxine— Effects of epinephrine may be potentiated by levothyroxine sodium.
Epinephrine 0.3 Adults + Levothyroxine Sodium— Effects of epinephrine may be potentiated by levothyroxine sodium.
Epinephrine 0.3 Adults + Monoamine Oxidase Inhibitors (Maois)— Effects of epinephrine may be potentiated by monoamine oxidase inhibitors.
Epinephrine 0.3 Adults + Phentolamine— Alpha-adrenergic blocking drug phentolamine antagonizes vasoconstricting and hypertensive effects of epinephrine.
Epinephrine 0.3 Adults + Propranolol— Beta-adrenergic blocking drug propranolol antagonizes cardiostimulating and bronchodilating effects of epinephrine.
Epinephrine 0.3 Adults + Tripelennamine— Effects of epinephrine may be potentiated by tripelennamine.

Epinephrine 0.3 Adults + Anti-Arrhythmics⚠️Major

Patients receiving epinephrine with anti-arrhythmics should be observed carefully for development of cardiac arrhythmias.

Epinephrine 0.3 Adults + Cardiac Glycosides⚠️Major

Patients receiving epinephrine with cardiac glycosides should be observed carefully for development of cardiac arrhythmias.

Epinephrine 0.3 Adults + Chlorpheniramine⚠️Major

Effects of epinephrine may be potentiated by chlorpheniramine.

Epinephrine 0.3 Adults + Diphenhydramine⚠️Major

Effects of epinephrine may be potentiated by diphenhydramine.

Epinephrine 0.3 Adults + Diuretics⚠️Major

Patients receiving epinephrine with diuretics should be observed carefully for development of cardiac arrhythmias.

Epinephrine 0.3 Adults + Ergot Alkaloids⚠️Major

Ergot alkaloids may reverse the pressor effects of epinephrine.

Epinephrine 0.3 Adults + Levothyroxine⚠️Major

Effects of epinephrine may be potentiated by levothyroxine sodium.

Epinephrine 0.3 Adults + Levothyroxine Sodium⚠️Major

Effects of epinephrine may be potentiated by levothyroxine sodium.

Epinephrine 0.3 Adults + Monoamine Oxidase Inhibitors (Maois)⚠️Major

Effects of epinephrine may be potentiated by monoamine oxidase inhibitors.

Epinephrine 0.3 Adults + Phentolamine⚠️Major

Alpha-adrenergic blocking drug phentolamine antagonizes vasoconstricting and hypertensive effects of epinephrine.

Epinephrine 0.3 Adults + Propranolol⚠️Major

Beta-adrenergic blocking drug propranolol antagonizes cardiostimulating and bronchodilating effects of epinephrine.

Epinephrine 0.3 Adults + Tripelennamine⚠️Major

Effects of epinephrine may be potentiated by tripelennamine.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.